2022 was a difficult year for Digital Health stock valuations as well as a down year for M&A and Private Placement activity.
Q2 2022 saw a precipitous drop in Digital Health stock values as well as 66% decline in the number of M&A deals but Private Placement activity held steady at robust levels
Q1 2022 M&A deal count up, Private Placement activity remains robust but stock performances down
Designed using Divogue Premium. Powered by WordPress.